PAR
Click for more information
0.00% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8

  1. mp28
    32 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    30/04/24
    10:35
    Post #: 73577174
    Apologies I should say “SHOULD definitely improve” IF the efficacy is what it has shown to be so far
    PAR Price at posting: 28.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

AZY Drilling doubles gold-copper mineralisation zone at GEO-01 for Antipa
right-arrow Created with Sketch.
NEWS Making the best of an inflationary environment
right-arrow Created with Sketch.
BB1 BlinkLab jumps as Dutch dementia study kicks off
right-arrow Created with Sketch.
TLX Telix kicks off $300M NASDAQ IPO offer, backed by Morgan Stanley
right-arrow Created with Sketch.
LU7 Lithium Universe inks final layout for Becancour lithium plant as DFS rolls on
right-arrow Created with Sketch.
LPM Lithium Plus inks spodumene offtake MOU with China's Canmax
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $85.7M
Open High Low Value Volume
24.5¢ 24.5¢ 24.5¢ $21.18K 86.48K

Buyers (Bids)

No. Vol. Price($)
9 191529 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 51596 7
View Market Depth
Last trade - 14.55pm 07/06/2024 (20 minute delay) ?
Last
25.0¢ 		  Change
0.000 ( 2.04 %)
Open High Low Volume
24.5¢ 25.0¢ 24.5¢ 55768
Last updated 14.55pm 07/06/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.